Schrodinger Stock Forecast
NASDAQ: SDGRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
SDGR analyst consensus
Consensus (7 analysts)
buy
Avg. price target
$33.57+46.40%
- Strong buy 0
- Buy 5
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 7 Wall Street analysts covering Schrodinger (2026-11-22), 5 rate the stock a buy or strong buy, 2 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $33.57, with a high estimate of $37.00 and a low estimate of $29.00. The average target implies upside of 46.4% from the current price of $22.93.
The spread between the highest and lowest targets is 27.6%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for SDGR.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 5 | 71% |
| Hold | 2 | 29% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-11-22.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $29.00 | +26.47% |
| Average target | $33.57 | +46.40% |
| High target | $37.00 | +61.36% |